Anthem Biosciences had a robust launch on the stock exchanges today. On the NSE, the stock began trading at ₹723.05 each, ...

Anthem Biosciences IPO listing was in line with the Street estimates as indicated by the grey market premium (GMP). Anthem ...

Anthem Biosciences Limited has made an initial public offering of equity shares aggregating to ₹3,395 crore. Trilegal ...

Contract research, development, and manufacturing organisation Anthem Biosciences shares recorded healthy returns on its ...

Anthem Biosciences shares are expected to make strong listing gains on the back of bumper subscription and strong GMP trends.

Anthem’s IPO did not include a fresh issue, with all proceeds going to existing shareholders. Prior to the IPO opening, ...

Anthem Biosciences shares listed at ₹723.10 per share on the BSE and ₹723.05 per share on the NSE, compared to the issue ...

Anthem Biosciences share price on the BSE was trading at Rs. 730.70, up Rs. 7.60 or 1.05% from the listing price and a 28.19% ...

Anthem Biosciences Ltd ended its debut trading day with a premium of over 28%. Despite the high opening figures, the company ...

Ahead of its listing, Anthem Biosciences was commanding a strong grey market premium (GMP) of ₹179 in the unlisted market, ...

Analysts said that Anthem Biosciences' IPO was fairly priced, supported by strong growth, industry-leading margins, and ...

Anthem Biosciences, a leading contract research and manufacturing organization (CRDMO), made a strong debut on the Indian ...